Evidence map›Paper›PMID 35612780›Full record

ArticleMolecular biology reports2022

BAG2 prevents Tau hyperphosphorylation and increases p62/SQSTM1 in cell models of neurodegeneration.

Raquel S Lima, Daniel C Carrettiero, Merari F R Ferrari

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. BAG2 Condensates Couple Proteostasis to CD8bioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Neuroprotective Mushrooms.NeuroImmune pharmacology and therapeutics · 2024
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Raquel S LimaDepartamento de Genetica e Biologia Evolutiva, Instituto de Biociencias, Universidade de Sao Paulo, Rua do Matao, 277, Cidade Universitaria, Sao Paulo, SP, 05508-090, Brazil.
Daniel C CarrettieroCentro de Ciencias Naturais e Humanas, Universidade Federal do ABC, Santo Andre, SP, Brazil.
Merari F R FerrariDepartamento de Genetica e Biologia Evolutiva, Instituto de Biociencias, Universidade de Sao Paulo, Rua do Matao, 277, Cidade Universitaria, Sao Paulo, SP, 05508-090, Brazil. merari@usp.br.ORCID http://orcid.org/0000-0001-7396-2196
Universidade de São Paulo · BRUniversidade Federal do ABC · BR

Funding

Fundação de Amparo à Pesquisa do Estado de São Paulo 2011/06434-7Fundação de Amparo à Pesquisa do Estado de São Paulo 2013/08028-1Fundação de Amparo à Pesquisa do Estado de São Paulo 2016/04409-9Fundação de Amparo à Pesquisa do Estado de São Paulo 2017/24722-6Fundação de Amparo à Pesquisa do Estado de São Paulo 2018/07592-4
6 · The paper itself

Abstract

backgroundProtein aggregates are pathological hallmarks of many neurodegenerative diseases, however the physiopathological role of these aggregates is not fully understood. Protein quality control has a pivotal role for protein homeostasis and depends on specific chaperones. The co-chaperone BAG2 can target phosphorylated Tau for degradation by an ubiquitin-independent pathway, although its possible role in autophagy was not yet elucidated. In view of this, the aim of the present study was to investigate the association among protein aggregation, autophagy and BAG2 levels in cultured cells from hippocampus and locus coeruleus as well as in SH-SY5Y cell line upon different protein aggregation scenarios induced by rotenone, which is a flavonoid used as pesticide and triggers neurodegeneration. METHODS AND

resultsThe present study showed that rotenone exposure at 0.3 nM for 48 h impaired autophagy prior to Tau phosphorylation at Ser199/202 in hippocampus but not in locus coeruleus cells, suggesting that distinct neuron cells respond differently to rotenone toxicity. Rotenone induced Tau phosphorylation at Ser199/202, together with a decrease in the endogenous BAG2 protein levels in SH-SY5Y and hippocampus cell culture, which indicates that rotenone and Tau hyperphosphorylation can affect this co-chaperone. Finally, it has been shown that BAG2 overexpression, increased p62/SQSTM1 levels in cells from hippocampus and locus coeruleus, stimulated LC3II recycling as well as prevented the raise of phosphorylated Tau at Ser199/202 in hippocampus.

conclusionsResults demonstrate a possible role for BAG2 in degradation pathways of specific substrates and its importance for the study of cellular aspects of neurodegenerative diseases.

Indexed as

NeuroblastomaRotenoneHumansMolecular ChaperonesProtein AggregatesSequestosome-1 Proteintau ProteinsBAG2 protein, humanMolecular ChaperonesProtein AggregatesRotenoneSequestosome-1 ProteinSQSTM1 protein, humantau ProteinsAlpha-synucleinAlzheimer’s diseaseAutophagyHyperphosphorylated TauParkinson’s diseaseRotenone

Identifiers

PMID35612780
OpenAlexW4281491018

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.